Health Library Logo

Health Library

What is Trabectedin: Uses, Dosage, Side Effects and More
What is Trabectedin: Uses, Dosage, Side Effects and More

Health Library

What is Trabectedin: Uses, Dosage, Side Effects and More

October 10, 2025


Question on this topic? Get an instant answer from August.

Trabectedin is a powerful chemotherapy medication used to treat certain advanced cancers, particularly soft tissue sarcomas and ovarian cancer. This medication works by interfering with cancer cell DNA, helping to slow or stop tumor growth when other treatments haven't been effective.

If your doctor has recommended trabectedin, you likely have questions about how it works and what to expect. Let's walk through everything you need to know about this treatment in clear, straightforward terms.

What is Trabectedin?

Trabectedin is a chemotherapy drug that comes from a marine organism called a sea squirt. It's given through an IV (intravenous) infusion directly into your bloodstream, allowing it to reach cancer cells throughout your body.

This medication belongs to a class of drugs called alkylating agents, which work by damaging the DNA inside cancer cells. When cancer cells can't repair this damage, they eventually die off, helping to shrink tumors or slow their growth.

Trabectedin is considered a specialty cancer treatment, meaning it's typically used when other more common chemotherapy drugs haven't worked well enough. Your oncologist will carefully consider your specific situation before recommending this medication.

What is Trabectedin Used For?

Trabectedin is primarily used to treat two types of advanced cancer. Your doctor may recommend it when your cancer has spread or hasn't responded well to other treatments.

The main conditions treated with trabectedin include advanced soft tissue sarcoma and recurrent ovarian cancer. Soft tissue sarcomas are cancers that develop in muscles, fat, blood vessels, or other supportive tissues throughout your body.

For ovarian cancer, trabectedin is typically used when the cancer has come back after previous chemotherapy treatments. It's often combined with another drug called pegylated liposomal doxorubicin to make the treatment more effective.

In some cases, doctors may also use trabectedin for other types of cancer as part of clinical trials or when standard treatments aren't suitable for your particular situation.

How Does Trabectedin Work?

Trabectedin works by getting inside cancer cells and binding tightly to their DNA. This binding prevents the cancer cells from copying their genetic material properly, which they need to do in order to divide and multiply.

Think of it like jamming the copying machine that cancer cells use to make more of themselves. When the DNA can't be copied correctly, the cancer cell realizes something is wrong and essentially shuts down permanently.

This medication is considered quite potent in the chemotherapy world. It's designed to target rapidly dividing cells, which is why it's effective against cancer but can also affect some healthy cells that divide quickly, like those in your hair follicles or digestive system.

The good news is that trabectedin tends to be more selective for cancer cells than some other chemotherapy drugs, potentially causing fewer side effects while still being effective against your cancer.

How Should I Take Trabectedin?

Trabectedin is always given as an IV infusion at a hospital or cancer treatment center. You can't take this medication at home since it requires careful monitoring by healthcare professionals.

The infusion typically takes about 3 hours to complete. Before your treatment, you'll receive anti-nausea medications to help prevent stomach upset, and your medical team will check your blood counts and liver function.

Most people receive trabectedin once every 3 weeks, giving your body time to recover between treatments. Your doctor will determine the exact dose based on your body size, overall health, and how well you're tolerating the medication.

Before each infusion, make sure to eat a light meal and stay well-hydrated. Avoid alcohol for at least 24 hours before treatment, as this can put extra stress on your liver while it's processing the medication.

How Long Should I Take Trabectedin For?

The length of trabectedin treatment varies significantly from person to person. Your oncologist will monitor how your cancer responds to the medication and how well your body tolerates it.

Some people may receive trabectedin for several months, while others might continue treatment for a year or longer if it's working well and side effects remain manageable. The key is finding the right balance between fighting your cancer and maintaining your quality of life.

Your doctor will regularly check your progress through blood tests, scans, and physical exams. If your cancer stops responding to trabectedin or if side effects become too difficult to manage, your treatment plan may be adjusted.

Remember that stopping trabectedin doesn't mean giving up on treatment. Your oncology team has many different approaches available and will work with you to find the best path forward for your specific situation.

What Are the Side Effects of Trabectedin?

Like all chemotherapy medications, trabectedin can cause side effects, though not everyone experiences them the same way. Understanding what to expect can help you prepare and know when to contact your medical team.

Here are the most common side effects you might experience:

  • Fatigue and weakness that may last several days after treatment
  • Nausea and vomiting, usually manageable with anti-nausea medications
  • Low blood cell counts, which can increase infection risk
  • Liver function changes, monitored through regular blood tests
  • Muscle and joint aches
  • Loss of appetite
  • Mild hair thinning (though complete hair loss is less common)

These common effects are generally manageable with supportive care and often improve as your body adjusts to the treatment schedule.

Less common but more serious side effects require immediate medical attention. These rare complications include severe liver problems, significant drops in blood cell counts that could lead to serious infections, and severe allergic reactions during infusion.

Some people may also experience heart rhythm changes, severe muscle weakness, or kidney problems. While these serious effects are uncommon, your medical team monitors you closely to catch any concerning changes early.

If you notice unusual symptoms like severe abdominal pain, difficulty breathing, irregular heartbeat, or signs of infection like fever, contact your oncology team right away.

Who Should Not Take Trabectedin?

Trabectedin isn't suitable for everyone, and your doctor will carefully review your medical history before recommending this treatment. Certain health conditions or medications can make trabectedin unsafe or less effective.

You should not receive trabectedin if you have severe liver disease, since your liver processes this medication and any existing liver problems could worsen. People with active, serious infections also need to wait until the infection clears before starting treatment.

Your doctor will also exercise caution if you have a history of heart problems, kidney disease, or if you're taking certain medications that could interact with trabectedin. Some drugs can affect how your body processes the medication, potentially making it more toxic.

Pregnant women cannot receive trabectedin since it can harm the developing baby. If you're of childbearing age, your medical team will discuss effective birth control methods during treatment and for several months afterward.

Age alone doesn't disqualify you from trabectedin treatment, but older adults may need closer monitoring or dose adjustments based on how well their organs are functioning.

Trabectedin Brand Names

Trabectedin is sold under the brand name Yondelis in most countries, including the United States and Europe. This is the most common name you'll see on your treatment records and medication information.

Some regions may have different brand names or generic versions, but the active ingredient remains the same. Your pharmacist or oncology team can clarify which specific formulation you're receiving.

When discussing your treatment with different healthcare providers, it's helpful to mention both the generic name (trabectedin) and the brand name (Yondelis) to avoid any confusion.

Trabectedin Alternatives

If trabectedin isn't suitable for you or stops working effectively, several alternative treatments are available. Your oncologist will consider your specific type of cancer, previous treatments, and overall health when selecting the best option.

For soft tissue sarcomas, alternatives might include other chemotherapy drugs like doxorubicin, ifosfamide, or pazopanib. Some newer targeted therapies and immunotherapy drugs are also showing promise for certain types of sarcomas.

For ovarian cancer, alternatives could include carboplatin, paclitaxel, topotecan, or newer drugs like PARP inhibitors for patients with certain genetic mutations. Clinical trials may also offer access to experimental treatments.

The key is working closely with your oncology team to find the treatment approach that offers the best chance of controlling your cancer while maintaining your quality of life.

Is Trabectedin Better Than Other Chemotherapy Drugs?

Trabectedin isn't necessarily "better" than other chemotherapy drugs, but it may be more effective for your specific situation. Different cancers respond to different treatments, and what works best varies from person to person.

For advanced soft tissue sarcomas, trabectedin has shown good results when other standard treatments haven't worked well. It may cause fewer severe side effects than some other chemotherapy combinations while still providing meaningful cancer control.

In ovarian cancer, trabectedin combined with pegylated liposomal doxorubicin has proven effective for recurrent disease. Studies suggest this combination can extend the time before cancer progresses compared to other available options.

Your oncologist chose trabectedin based on scientific evidence about what works best for your specific type and stage of cancer. Trust that this recommendation comes from careful consideration of your individual circumstances.

Frequently asked questions about Trabectedin (intravenous route)

Trabectedin requires careful liver function monitoring, and people with significant liver disease may not be good candidates for this treatment. Your liver processes trabectedin, so existing liver problems could worsen during treatment.

Before starting trabectedin, your doctor will run blood tests to check how well your liver is working. These tests continue throughout treatment to catch any changes early. If your liver function declines, your dose may need adjustment or treatment may need to stop.

Having mild liver function abnormalities doesn't automatically disqualify you from trabectedin, but it does mean you'll need closer monitoring and possibly lower doses to keep you safe.

Trabectedin overdose is extremely rare since it's given by trained medical professionals in controlled settings. However, if you ever suspect an error in your treatment, speak up immediately.

If too much trabectedin is given, your medical team will monitor you closely for increased side effects, particularly liver problems and severely low blood counts. They may give you medications to help protect your organs and support your body's recovery.

The good news is that trabectedin is always administered in hospitals or cancer centers where medical staff can respond quickly to any complications. Never hesitate to ask questions about your treatment or voice any concerns.

If you miss a scheduled trabectedin infusion, contact your oncology team as soon as possible to reschedule. Don't try to make up for a missed dose by receiving extra medication later.

Your doctor will determine the best timing for your next treatment based on how long it's been since your last dose and how your body is recovering. Sometimes a brief delay can actually be beneficial if you're dealing with side effects.

Missing one treatment doesn't mean your cancer treatment plan is ruined. Your oncology team can adjust your schedule while still maintaining the effectiveness of your overall treatment plan.

You can stop taking trabectedin when your doctor determines it's no longer beneficial or if side effects become too difficult to manage. This decision should always be made together with your oncology team.

Common reasons to stop include if your cancer stops responding to the medication, if you develop serious side effects, or if your overall health declines. Sometimes treatment breaks are planned to give your body time to recover.

Stopping trabectedin doesn't mean stopping cancer treatment entirely. Your oncologist will have alternative treatment options ready and will work with you to transition smoothly to the next phase of your care.

Most people feel tired after trabectedin infusion, so it's best to arrange for someone to drive you home after treatment. The fatigue can last for several days, affecting your ability to drive safely.

Some people also experience nausea or dizziness after treatment, which can make driving dangerous. Plan to have a family member or friend available to help with transportation, especially for the first few treatments.

As you get used to how trabectedin affects you, you may find that you can drive again a day or two after treatment. Listen to your body and don't drive if you feel tired, dizzy, or unwell.

Health Companion

trusted by

6Mpeople

Get clear medical guidance
on symptoms, medications, and lab reports.

QR code to download August

download august